Biology of pancreatic cancer
- PMID: 1855689
- PMCID: PMC1379000
- DOI: 10.1136/gut.32.7.800
Biology of pancreatic cancer
Abstract
Pancreatic cancer is the fifth leading cause of death from malignant disease in Western society. Apart from the fortunate few patients who present with a resectable small pancreatic adenocarcinoma, conventional treatment offers no hope of cure and has little palliative value. Over the past two decades major steps have been made in our understanding of the biology of pancreatic growth and neoplasia. This review sets out to explore these advances, firstly in the regulation of normal pancreatic growth, and secondly the mechanism which may be involved in malignant change of the exocrine pancreas. From an understanding of this new biology, new treatment strategies may be possible for patients with pancreatic cancer.
Similar articles
-
Hormonal therapy of pancreatic carcinoma. Rationale and perspectives.Int J Pancreatol. 1993 Jun;13(3):159-68. doi: 10.1007/BF02924436. Int J Pancreatol. 1993. PMID: 8103783 Review.
-
Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype.Adv Exp Med Biol. 2013;779:91-143. doi: 10.1007/978-1-4614-6176-0_5. Adv Exp Med Biol. 2013. PMID: 23288637 Review.
-
Differentiation of chronic pancreatitis from pancreatic cancer: recent advances in molecular diagnosis.Dig Dis. 2001;19(1):32-6. doi: 10.1159/000050651. Dig Dis. 2001. PMID: 11385249 Review.
-
Pancreatic cancer: a review of emerging therapies.Drugs. 2000 May;59(5):1071-89. doi: 10.2165/00003495-200059050-00004. Drugs. 2000. PMID: 10852640 Review.
-
Growth factors in development and diseases of the exocrine pancreas.Pancreatology. 2001;1(1):15-23. doi: 10.1159/000055787. Pancreatology. 2001. PMID: 12120262 Review. No abstract available.
Cited by
-
Somatostatin and the treatment of pancreatic cancer.Ann R Coll Surg Engl. 1994 May;76(3):172-4. Ann R Coll Surg Engl. 1994. PMID: 7912488 Free PMC article. Review. No abstract available.
-
On the role of cholecystokinin in pancreatic cancer.Int J Pancreatol. 1995 Apr;17(2):121-38. doi: 10.1007/BF02788530. Int J Pancreatol. 1995. PMID: 7622936 Review. No abstract available.
-
Treatment of pancreatic cancer. Promises and problems of tamoxifen, somatostatin analogs, and gemcitabine.Int J Pancreatol. 1997 Oct;22(2):81-93. doi: 10.1007/BF02787465. Int J Pancreatol. 1997. PMID: 9387029 Review.
-
Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas.Br J Cancer. 1997;75(10):1467-73. doi: 10.1038/bjc.1997.251. Br J Cancer. 1997. PMID: 9166939 Free PMC article.
-
Atypical acinar cell foci in human pancreas. Morphological and morphometric analysis.Int J Pancreatol. 1997 Oct;22(2):127-30. doi: 10.1007/BF02787470. Int J Pancreatol. 1997. PMID: 9387034
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous